These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 22216287)
1. Estrogen-mediated upregulation of Noxa is associated with cell cycle progression in estrogen receptor-positive breast cancer cells. Liu W; Swetzig WM; Medisetty R; Das GM PLoS One; 2011; 6(12):e29466. PubMed ID: 22216287 [TBL] [Abstract][Full Text] [Related]
2. RASSF1A inhibits estrogen receptor alpha expression and estrogen-independent signalling: implications for breast cancer development. Thaler S; Schmidt M; Schad A; Sleeman JP Oncogene; 2012 Nov; 31(47):4912-22. PubMed ID: 22266866 [TBL] [Abstract][Full Text] [Related]
3. Signal transducer and activator of transcription 5b, c-Src, and epidermal growth factor receptor signaling play integral roles in estrogen-stimulated proliferation of estrogen receptor-positive breast cancer cells. Fox EM; Bernaciak TM; Wen J; Weaver AM; Shupnik MA; Silva CM Mol Endocrinol; 2008 Aug; 22(8):1781-96. PubMed ID: 18550772 [TBL] [Abstract][Full Text] [Related]
4. The role of estrogen receptor alpha in mediating chemoresistance in breast cancer cells. Jiang Z; Guo J; Shen J; Jin M; Xie S; Wang L J Exp Clin Cancer Res; 2012 May; 31(1):42. PubMed ID: 22553917 [TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor α dependent regulation of estrogen related receptor β and its role in cell cycle in breast cancer. Madhu Krishna B; Chaudhary S; Mishra DR; Naik SK; Suklabaidya S; Adhya AK; Mishra SK BMC Cancer; 2018 May; 18(1):607. PubMed ID: 29843638 [TBL] [Abstract][Full Text] [Related]
6. Estrogen induces Vav1 expression in human breast cancer cells. Du MJ; Chen XD; Zhou XL; Wan YJ; Lan B; Zhang CZ; Cao Y PLoS One; 2014; 9(6):e99052. PubMed ID: 24905577 [TBL] [Abstract][Full Text] [Related]
7. Autocrine regulation of cell proliferation by estrogen receptor-alpha in estrogen receptor-alpha-positive breast cancer cell lines. Tan H; Zhong Y; Pan Z BMC Cancer; 2009 Jan; 9():31. PubMed ID: 19171042 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms of estrogen receptor antagonism toward p53 and its implications in breast cancer therapeutic response and stem cell regulation. Konduri SD; Medisetty R; Liu W; Kaipparettu BA; Srivastava P; Brauch H; Fritz P; Swetzig WM; Gardner AE; Khan SA; Das GM Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15081-6. PubMed ID: 20696891 [TBL] [Abstract][Full Text] [Related]
9. Regulation of ERalpha-mediated transcription of Bcl-2 by PI3K-AKT crosstalk: implications for breast cancer cell survival. Bratton MR; Duong BN; Elliott S; Weldon CB; Beckman BS; McLachlan JA; Burow ME Int J Oncol; 2010 Sep; 37(3):541-50. PubMed ID: 20664923 [TBL] [Abstract][Full Text] [Related]
10. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft. Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847 [TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of Estrogen Receptor α at serine 118 directs recruitment of promoter complexes and gene-specific transcription. Duplessis TT; Williams CC; Hill SM; Rowan BG Endocrinology; 2011 Jun; 152(6):2517-26. PubMed ID: 21505052 [TBL] [Abstract][Full Text] [Related]
12. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells. Albanito L; Madeo A; Lappano R; Vivacqua A; Rago V; Carpino A; Oprea TI; Prossnitz ER; Musti AM; Andò S; Maggiolini M Cancer Res; 2007 Feb; 67(4):1859-66. PubMed ID: 17308128 [TBL] [Abstract][Full Text] [Related]
13. Estrogen-induced interaction between KLF5 and estrogen receptor (ER) suppresses the function of ER in ER-positive breast cancer cells. Guo P; Dong XY; Zhao KW; Sun X; Li Q; Dong JT Int J Cancer; 2010 Jan; 126(1):81-9. PubMed ID: 19569049 [TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor α attenuates therapeutic efficacy of paclitaxel on breast xenograft tumors. Chang J; Sui M; Fan W Breast Cancer Res Treat; 2012 Aug; 134(3):969-80. PubMed ID: 22374518 [TBL] [Abstract][Full Text] [Related]
15. Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor α and β. Rossi V; Bellastella G; De Rosa C; Abbondanza C; Visconti D; Maione L; Chieffi P; Della Ragione F; Prezioso D; De Bellis A; Bellastella A; Sinisi AA J Cell Physiol; 2011 May; 226(5):1334-9. PubMed ID: 20945400 [TBL] [Abstract][Full Text] [Related]
17. From the Cover: Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response. Laganière J; Deblois G; Lefebvre C; Bataille AR; Robert F; Giguère V Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11651-6. PubMed ID: 16087863 [TBL] [Abstract][Full Text] [Related]
18. Maximum growth and survival of estrogen receptor-alpha positive breast cancer cells requires the Sin3A transcriptional repressor. Ellison-Zelski SJ; Alarid ET Mol Cancer; 2010 Sep; 9():263. PubMed ID: 20920219 [TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor-dependent regulation of CYP2B6 in human breast cancer cells. Lo R; Burgoon L; Macpherson L; Ahmed S; Matthews J Biochim Biophys Acta; 2010; 1799(5-6):469-79. PubMed ID: 20079471 [TBL] [Abstract][Full Text] [Related]
20. Aryl hydrocarbon receptor modulation of estrogen receptor α-mediated gene regulation by a multimeric chromatin complex involving the two receptors and the coregulator RIP140. Madak-Erdogan Z; Katzenellenbogen BS Toxicol Sci; 2012 Feb; 125(2):401-11. PubMed ID: 22071320 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]